Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance.
about
Antiviral drugs for viruses other than human immunodeficiency virusKASL clinical practice guidelines: management of hepatitis CReplicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-responseImproving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load CriteriaEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus InfectionFactors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyAnalysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological responseSymptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a.Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CVirological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infectionHepatitis C virus virology and new treatment targets.Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.Development of prophylactic and therapeutic vaccines against hepatitis C virus.Pegylated interferon and ribavirin treatment for hepatitis C virus infection.Treating viral hepatitis C: efficacy, side effects, and complications.Improving anti-hepatitis C virus therapy.Present and future therapy for hepatitis C virus.IFN-α subtypes: distinct biological activities in anti-viral therapy.Acute hepatitis C in an HIV-infected patient: a case report and review of literatureRole of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.Acute hepatitis C: a systematic review.Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Treatment of acute HCV infection.Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.Natural killer cells in hepatitis C virus infection.Acute hepatitis C: management in the rapidly evolving world of HCV.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.APASL consensus statements and management algorithms for hepatitis C virus infection.Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.Acute hepatitis C in Korea: different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion.Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure.Transmission of hepatitis C virus by needle-stick injury in community settings.
P2860
Q24635330-51C65A9F-B4C6-4E17-80D0-B1F1AE55183DQ26752471-A06335B0-2A85-491A-8F2B-57847B32D61EQ27478215-BF8929A4-95E3-495C-B66A-9020A107C5F4Q27489594-A8AF66BE-8478-4E2D-931D-04EF3CFC3152Q27490862-A8C684AB-C5DD-4852-9557-4C496809E6D6Q27491349-17892523-DA9B-4BFE-AF2E-BA89865D2F56Q28481489-4E10E5E3-F74F-410F-8DB2-278719110A13Q33396464-2A875889-BA98-44C8-A3D7-03EB6584DF18Q33955516-E5E887AF-710C-4409-9FEE-2FF0221785D7Q34714349-F8FB4950-D22F-47C1-9CC9-5AA8380BD7EBQ34779758-14F2C5A3-07B9-4A87-830F-CB6712FFD6BEQ34974042-8850BA4F-C5E8-43C2-A6AC-FE3791212A91Q35053344-1E8DBC5D-0332-4A13-B119-4A27A1F6AB67Q36063808-C8FD2125-0D69-4A5C-B6D4-F6C75CBDFB6EQ36198667-CFA5AEB7-62F1-45D8-A339-394E54BEFC3CQ36443698-4E870A14-9CFD-42E2-8CCA-0A624F9D1E25Q36564615-CD8D4604-C534-4BDF-8F4F-C721162B93A3Q36569749-867A17A8-DDEE-4086-ADD5-8DAC0428A7DFQ36670887-C9BA2A66-FF96-451B-8079-12B832F5205FQ36675798-A5D290C3-D763-464F-99E6-5AE5E1340B11Q36780300-7B3F082D-13E3-4988-9262-A8F53B81F12BQ37111632-B2F24FF4-9993-4800-8856-E0EB19BE894EQ37161958-ADA37290-0C98-4C23-9C10-D80BA6BA979DQ37162708-7EF30633-6AC1-4746-BDBC-97CD677FFF25Q37255644-1A62E0E7-F936-4D94-B7A9-655AF64186B3Q37831965-72229D5D-EFAD-4F3E-9326-C0C219AFC0D9Q37855530-A1602185-4795-4B5B-8D8E-771BDB9E34ADQ38050166-EF35FF89-FB84-436A-8C42-AD480BD4334CQ38061192-3B3E9C0E-2C72-45E4-9A89-A04EDCFB0813Q38183312-35016F94-7544-41C7-96DC-AB9B08D61433Q38195262-ABA69045-79F3-4E97-9A31-D205FC70BA32Q38552131-1870023D-F7B9-4E99-9B9A-C2E562619562Q39084627-ADB7091B-6190-427A-9F18-F4135181E798Q39712175-30897B2D-6B9B-4C04-8D2D-372DF707DF2CQ41855937-EB589A2B-E09F-4FB5-B32E-696A2C0686BBQ42232261-C2D42F58-D46A-4F1C-A51C-5B8E140AD567Q43032166-DEB5273C-BF6C-45C4-9B31-1518019AFA08Q43036767-8E6086D7-EFBC-4258-B31F-4D958610523BQ43037174-9B06B04B-8617-471F-8900-539CB87E6C5CQ43041155-6DFD823B-5FD6-4A83-9DB8-04C6F36D162F
P2860
Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@en
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@nl
type
label
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@en
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@nl
prefLabel
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@en
Efficacy of a 24-week course o ...... lure of spontaneous clearance.
@nl
P2093
P1476
Efficacy of a 24-week course o ...... ilure of spontaneous clearance
@en
P2093
Angela Guastadisegni
Caterina Casalino
Emanuele Sinisi
Giuseppe Pastore
Massimo Fasano
Michele Mazzola
Teresa Santantonio
P304
P356
10.1016/J.JHEP.2004.11.021
P577
2005-03-01T00:00:00Z